SummitTX Capital’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$534K Buy
40,000
+9,116
+30% +$122K 0.02% 494
2025
Q1
$315K Buy
+30,884
New +$315K 0.01% 649